AMGEN Inc. (AMGN) The Story Behind The Stats: Analyzing Their Latest Financial Filing
The company’s revenue growth has been affected by increasing competition, including biosimilars and generics. They rely on discovering, developing, and commercializing innovative products, as well as acquiring or collaborating on therapies from other companies. Regulatory scrutiny and uncertain macroeconomic conditions further impact revenue growth. The COVID-19 pandemic has resulted in reduced demand and disrupted physician-patient […]
Source: dailypolitical.com